The study has been designed with the help of experts from Germany, UK, Italy, Poland, Moldova, and Indonesia. SMILE study is being conducted in four dental clinics across four different countries (Italy, Poland, Moldova, and Indonesia). Volunteer enrollment was completed in August 2023 and results will be expected to be available in 2025.
On Tuesday, February 20th, the MAGNIFICAT Project, coordinated by CoEHAR, hosted a pivotal workshop in Warsaw, Poland, to bring together all partners involved in in-depth discussions and hands-on exercises focusing…
Data confirms that there is high certainty that nicotine electronic cigarettes increases quit rates compared to nicotine replacement therapy.
The CoEHAR Council (made up of 71 of the 95 members of the Center of Excellence of the University of Catania), meeting in an online session, reconfirmed their trust in…
In order to continue a positive collaboration with the partners, CoEHAR researchers organized the Annual Replica International Meeting which will be held at the Torre Biologica in Catania, Italy from 25th to 29th March.
The study marks the first of its kind, shedding light on a novel aspect of oral health among users of combustion-free nicotine products. These findings underscore the aesthetic benefits associated with ECs and HTPs use, signifying a significant departure from the well-known dental color implications of tobacco smoking. As patients increasingly prioritize aesthetics, evident in the growing prevalence of purely cosmetic dental procedures, and with smoking being a prevalent factor, this result serves as a compelling incentive to quit smoking.
A group of researchers from the University of Catania conducted a review on numerous available databases to assess the effectiveness of protocols using magnetic stimulation to treat gambling disorders. A…
On 19th January, in Hotel Palace Catania, there was a Kick-Off meeting held by CoEHAR, its Partners: ABF GmbH from Germany, PRATIA MTZ from Poland and supporting Parties such as…
This study, strongly advocated by Prof. Riccardo Polosa, aims to investigate the consequences of the combined use of conventional cigarettes and electronic cigarettes on human health.
The study found that the antismoking medication varenicline can increase rates of smoking abstinence without causing serious adverse events.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.